Dr. Alan D. Snow is Founder & CEO of Cognitive Clarity Inc. and former Research Associate Professor of Pathology at University of Washington in Seattle, where he was an Alzheimer’s Disease Research Center project team leader for over 10 years. He obtained his BS in Biology and Chemistry from Bowling Green State University (Bowling Green, Ohio); MS in Anatomy from University of Western Ontario (London, Ontario, Canada); and PhD in Pathology from Queen’s University (Kingston, Ontario, Canada).
Dr. Snow has been studying and researching brain health, memory, cognition and brain plaques and tangles for over 30 years.
Dr. Snow did a postdoctoral fellowship in Dr. Thomas Wight’s lab in the Department of Pathology at University of Washington (Seattle, WA). Dr. Snow immediately made the discovery of identifying specific heparan sulfate proteoglycans in the plaques and cerebrovascular deposits in Alzheimer’s disease and Down’s Syndrome. Dr. Snow then completed innovative work with Dr. Stanley Prusiner and discovered that specific heparan sulfate proteoglycans were also in the plaques in prion diseases (i.e. “mad-cow” and other infectious brain diseases ). Dr. Prusiner then went on to win the Nobel Prize in Physiology or Medicine in 1997.
Dr. Snow led a world-class research team in the Department of Pathology at the University of Washington (Seattle, WA, USA) involved in research pertaining to brain plaque and tangle formation, and the discovery of compounds and nutraceuticals able to prevent/reduce brain plaque load and improve memory. Dr. Snow left the University in 1999 to form a private Company to develop small molecule drugs. Dr. Snow’s research led to 18 National Institute of Health (NIH) grant awards, and a prestigious $3.5M LEAPS award from the Michael J. Fox Foundation for Parkinson’s Disease Research. Dr. Snow published over 50 peer-reviewed publications, made presentations at over 100 scientific meetings worldwide, and is an inventor on over 340 issued patents pertaining to new drugs and nutraceuticals for brain aging, Alzheimer’s, Parkinson’s, and other amyloid disorders, as well as discovering new animal models and screening technologies.
Dr. Snow’s world-class research teams have made significant discoveries and inventions pertaining to disease modifying therapeutics for amyloid diseases including Alzheimer’s, Parkinson’s, type 2 diabetes and systemic amyloidosis, as well as inventions pertaining to novel platform screening technologies, and new diagnostics. His discoveries on nutraceuticals and nutraceutical ingredients to target normal brain aging and memory loss are postulated to be a breakthrough in the years to come.
Dr. Snow has been studying and researching brain health, memory, cognition and brain plaques and tangles for over 30 years. His scientific and neuropathology background has led him to be one of the most knowledgeable neuroscientists in this field in the world today.